2 Patents
- US125655232026Structure-guided Engineering of Peptide-based NLRP3 Inflammasome Inhibitors for Myelodysplastic Syndromes (MDS)
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.
0 cites - 0 cites
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.